Common vitamins can help prevent Skin cancer developmentnew research suggests.
This study, published in Jama Dermatology, found that the risk of three types of skin cancer associated with the use of nicotinamide was reduced. Vitamin B3.
The study examined health data from over 33,000 veterans between 1999 and 2024 and retracted them from Veterans (VA) records.
Common daily vitamins that have been shown to slow the aging process in 4 years
Patients taking nicotinamide matched similar patients who did not based on characteristics such as age, gender, race, skin cancer history, and exposure to other treatments.
Researcher We also considered whether the patient had a history of organ transplant disease and whether he had a health condition such as chronic lymphocytic leukemia.
Within the study group, 12,287 patients were compared with 21,479 patients who were exposed to oral vitamin B3 at 500 mg twice daily for more than 30 days and did not take it.
Researchers found fewer patients took vitamin B3 Overall skin cancer.
The risk of developing skin cancer, including basal cell carcinoma and squamous cell carcinoma, was reduced by approximately 14% when exposed to supplements.
The researchers also looked at the rate of skin cancer recurrence and noted that those who started taking nicotinamide shortly after their initial skin cancer diagnosis had a 54% reduction in the risk of the disease returning. After being diagnosed with multiple skin cancers, benefits were less important.
Click here to sign up for our health newsletter
Patients with Organ transplantation Unless you were beginning to take Vitamin B3 early, there was no significant difference in overall risk.
These results “suggest a reduced risk of skin cancer in patients treated with nicotinamide, with the greatest effect seen when initiated after the initial skin cancer,” the researchers wrote.
In a recent episode of the Jamadermatology podcast, Dr. Lee Weras, a co-researcher at Vanderbilt University Medical Center in Tennessee, discussed the link between skin cancer recurrence and nicotinamide exposure.
The doctor said he wouldn’t recommend anyone who would get it first. Skin cancer “Suddenly” diagnosis begins taking nicotinamide, but the findings say it “changed” his thinking.
shout
“If a patient already has that field cancer, I really ask. Is this effective as if we had started before?” he asked. “I think we’re all really good at seeing lots of patients. [skin damage]they have some skin cancer and you only get this feeling that they are wobbling at the edges that explode with many skin cancers. ”
For health articles, please visit foxnews.com/health
“This means we don’t have to start now and wait for that sixth, seventh or more skin cancer before we start doing something preventative.”
Fox News Digital has requested the study authors for comment.
